Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07219771) titled 'A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients' on Oct. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Doron Therapeutics Inc.
Condition:
Knee Osteoarthritis
Intervention:
Biological: PTP-01
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: October 14, 2025
Target Sample Size: 260
Countries of Recruitment:
Australia
To know more, visit https://clinicaltrials.gov/study/NCT072197...